Exponent, Inc. (NASDAQ:EXPO) Director Sells $123,539.00 in Stock

Exponent, Inc. (NASDAQ:EXPO) Director Paul R. Johnston sold 1,300 shares of the business’s stock in a transaction on Wednesday, November 20th. The stock was sold at an average price of $95.03, for a total transaction of $123,539.00. Following the transaction, the director now directly owns 59,406 shares in the company, valued at $5,645,352.18. This trade represents a 2.14 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink.

Exponent Price Performance

Shares of Exponent stock opened at $98.04 on Friday. The firm has a market capitalization of $4.98 billion, a PE ratio of 47.36 and a beta of 0.69. The company’s fifty day moving average price is $106.31 and its two-hundred day moving average price is $102.07. Exponent, Inc. has a 52-week low of $68.70 and a 52-week high of $115.75.

Exponent Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, December 20th. Shareholders of record on Friday, December 6th will be issued a $0.28 dividend. This represents a $1.12 annualized dividend and a yield of 1.14%. The ex-dividend date is Friday, December 6th. Exponent’s dividend payout ratio (DPR) is presently 54.11%.

Institutional Investors Weigh In On Exponent

Institutional investors and hedge funds have recently bought and sold shares of the business. Vanguard Group Inc. boosted its stake in shares of Exponent by 5.8% in the 1st quarter. Vanguard Group Inc. now owns 5,286,652 shares of the business services provider’s stock valued at $437,153,000 after purchasing an additional 291,047 shares in the last quarter. Kayne Anderson Rudnick Investment Management LLC boosted its stake in shares of Exponent by 6.5% in the 2nd quarter. Kayne Anderson Rudnick Investment Management LLC now owns 4,640,600 shares of the business services provider’s stock valued at $441,414,000 after purchasing an additional 284,179 shares in the last quarter. Conestoga Capital Advisors LLC boosted its stake in shares of Exponent by 1.6% in the 3rd quarter. Conestoga Capital Advisors LLC now owns 2,806,517 shares of the business services provider’s stock valued at $323,535,000 after purchasing an additional 43,257 shares in the last quarter. State Street Corp boosted its stake in shares of Exponent by 0.7% in the 3rd quarter. State Street Corp now owns 1,840,313 shares of the business services provider’s stock valued at $212,151,000 after purchasing an additional 13,644 shares in the last quarter. Finally, Geneva Capital Management LLC boosted its stake in shares of Exponent by 1.7% in the 3rd quarter. Geneva Capital Management LLC now owns 1,590,804 shares of the business services provider’s stock valued at $183,388,000 after purchasing an additional 27,339 shares in the last quarter. Institutional investors own 92.37% of the company’s stock.

Wall Street Analysts Forecast Growth

Separately, Truist Financial reissued a “buy” rating and issued a $120.00 price target (up previously from $100.00) on shares of Exponent in a report on Friday, July 26th.

Exponent Company Profile

Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.